FDA approves Gilead's breakthrough hepatitis C pill
(Reuters) - U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a potential cure for chronic infection with...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/6DDXwfl0lWo/story01.htm
No comments:
Post a Comment